Clinical Trials Directory

Trials / Completed

CompletedNCT02544893

Postoperative Analgesic Effects of Using Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block

Postoperative Analgesic Effects of Using Bupivacaine Alone or Added Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block in Thoracotomy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
93 (actual)
Sponsor
TC Erciyes University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

we aimed postoperative analgesic effects of using bupivacaine alone or added dexmedetomidine for ultrasound guided thoracic paravertebral block in thoracotomy

Detailed description

paravertebral block is commonly used in the treatment for acute and chronic pain.The duration of paravertebral block could theoretically be prolonged with neurolytic agents. Dexmedetomidine ,an alfa-2 adrenoreceptor agonist, is being used and adjuvant capable of prolonging duration of sensory and motor block on nerve blocks.

Conditions

Interventions

TypeNameDescription
DRUGbupivacaine21 ml 0.5 %bupivacaine is applied paravertebral space
DRUGdexmedetomidin1 ml dexmedetomidin + 20 ml 0.5 % bupivacaine are applied paravertebral space
DRUGserum physiologic21 ml serum physiologic is applied paravertebral space

Timeline

Start date
2015-09-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2015-09-09
Last updated
2016-08-03

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02544893. Inclusion in this directory is not an endorsement.